Over the next two decades, the number of diseases associated with smoking will significantly decrease as a result of the transition to alternative low-risk products - GFN 2021
Although the Global Forum on Nicotine (GFN-2021), held in Liverpool, Home of harm reduction, the focus of professionals and doctors was on safe alternatives in the fight against death and smoking-related illness. Dr. David O'Reilly, Research Team Member and Director of Research and Development at British American Tobacco (BAT), noted at the forum that the global public health strategy is aimed at minimizing the negative health effects of smoking by encouraging smokers to quit and those who continue to smoke - switch to alternative nicotine consumption products. Therefore, tobacco companies need to ensure that adult smokers have continued access to high quality, widely tested nicotine products that can reduce the health risks of smoking to individuals and society. “The first e-cigarette from BAT, introduced in 2003, was a very simple device. Today at BAT we offer not only a range of vaporizing products, but also tobacco heating products and oral nicotine packs. All of this represents a significantly lower risk compared to constant smoking, says David O'Reilly. - Currently, the number of consumers of alternative BAT products around the world is 15 million people. This trend towards product innovation and change will continue in the future. We have set an ambitious target of 50 million non-flammable consumers by 2030. ” Sweden is a good example of a switch to alternative nicotine products, where snus use has contributed to the fact that Sweden has the lowest cancer incidence rate, as evidenced by decades of observation. “Applying this practice in other markets will demonstrate that the BAT A Better TomorrowTM program will reduce negative health impacts and increase the company's business resilience,” said David O'Reilly. // 08.07.2021 — InfoMarket
